Doctors have been prescribing Roche's cancer drug Avastin off-label to treat some of the same vision problems as its eye drug, Lucentis. Now, Italy's antitrust authority has fined Roche and marketing partner Novartis,<span style="font-size: 13px;"> accusing them of colluding to push doctors toward the pricier option–claims the pair denies.</span>
written on 05.03.2014